# LigoCyte Pharmaceuticals Inc: Form D filings

LigoCyte Pharmaceuticals Inc, a pharmaceuticals company in Bozeman, MT, filed 5 Form D notices with the SEC between 2009 and 2012. The latest, on June 28, 2012, reports $2 million sold of a $22.1 million offering to 7 investors.

Find out what LigoCyte Pharmaceuticals Inc does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.

- [Watch for new raises](https://specstream.ai/workspace/ask?q=Tell%20me%20when%20LigoCyte%20Pharmaceuticals%20Inc%20files%20a%20new%20Form%20D%20or%20reports%20more%20money%20sold%2C%20with%20the%20filing&src=data-formd&kind=alert&entity=LigoCyte%20Pharmaceuticals%20Inc&page=%2Fdata%2Fform-d%2Fcompany%2Fligocyte-pharmaceuticals-inc-1400794)
- [Get founders and investors](https://specstream.ai/workspace/ask?q=For%20LigoCyte%20Pharmaceuticals%20Inc%2C%20find%20what%20the%20company%20does%2C%20its%20website%2C%20the%20founders%20and%20executives%20with%20their%20LinkedIn%20and%20work%20email%2C%20its%20investors%20and%20every%20funding%20round%20with%20the%20amounts%2C%20its%20headcount%20and%20any%20reported%20valuation&src=data-formd&kind=record&entity=LigoCyte%20Pharmaceuticals%20Inc&page=%2Fdata%2Fform-d%2Fcompany%2Fligocyte-pharmaceuticals-inc-1400794)

## The full lists

This record is a row of these lists. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, street, city, state, ZIP and 4 more), which open on your screen as soon as the payment clears and come by email.

- [Form D filings in Montana](https://specstream.ai/data/form-d/state/montana): 99 rows, by operating companies, filed since November 1, 2024, $5, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/state/montana
- [Form D filings in Pharmaceuticals](https://specstream.ai/data/form-d/industry/pharmaceuticals): 346 rows, by operating companies, filed since November 1, 2024, $17.30, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/industry/pharmaceuticals

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

## Company details from the filing

- Address: 2155 Analysis Drive, Bozeman, MT, 59718
- Phone: (406) 585-2733
- Industry: Pharmaceuticals
- Entity type: Corporation
- Incorporated in: Delaware
- Year incorporated: 2008
- Revenue range: Decline to Disclose
- Exemptions claimed: Rule 506
- SEC identifier (CIK): 1400794

## Form D filings

| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Jun 28, 2012 | New notice | $22,094,465 | $2,000,000 | $20,094,465 | 7 | Jun 21, 2012 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1400794/000140079412000001/0001400794-12-000001-index.htm) |
| Jun 21, 2011 | New notice | $13,080,283 | $5,500,000 | $7,580,283 | 11 | Jun 7, 2011 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1400794/000140079411000001/0001400794-11-000001-index.htm) |
| May 28, 2010 | Amendment | $14,661,296 | $6,572,305 | $8,088,991 | 15 | Apr 9, 2010 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1400794/000140079410000002/0001400794-10-000002-index.htm) |
| Apr 22, 2010 | New notice | $14,500,000 | $6,500,000 | $8,000,000 | 11 | Apr 9, 2010 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1400794/000140079410000001/0001400794-10-000001-index.htm) |
| Aug 14, 2009 | Amendment | $29,490,335 | $29,490,335 | $0 | 23 | Mar 18, 2008 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1400794/000140079409000004/0001400794-09-000004-index.htm) |

## Executive officers and directors named in the filing

| Name | Role | Note in the filing |
| --- | --- | --- |
| Larry Mikkola | Executive Officer |  |
| Ivor Royston | Director |  |
| C. Boyd Clarke | Executive Officer, Director |  |
| Robert Goodwin | Executive Officer |  |
| Donald Beeman | Executive Officer, Director |  |
| Ben Auspitz | Director |  |
| J. Donald deBethizy | Director |  |
| Hironori Boyd Hozoji | Director |  |
| Markus Boyd Goebel | Director |  |

[Every Form D from the week of Jun 25, 2012](https://specstream.ai/data/form-d/week/2012-06-25) · [All recent filings in Montana](https://specstream.ai/data/form-d/state/montana) · [All recent Pharmaceuticals filings](https://specstream.ai/data/form-d/industry/pharmaceuticals)

Read from SEC EDGAR. Amount sold is what LigoCyte Pharmaceuticals Inc reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under [CC BY 4.0](https://creativecommons.org/licenses/by/4.0/).